- World rank, all time
- #31,767 of 42,892
- Rank in Ireland
- #107 of 152
- Research works
- 145 ▼ 7% vs 2013–17
- Citations
- 1.6k 11.4 per fractional work
- Top-10% rate
- 10.4% record average 16.5%
- Open access
- 46% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 12.4×. Every wedge is a field page.
- Economics, Econometrics and Finance 12.4×
- Medicine 2.9×
- Health Professions 2.3×
- Immunology and Microbiology 1.9×
- Nursing 1.1×
- Mathematics 0.8×
- Neuroscience 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Decision Sciences 0.4×
- Business, Management and Accounting 0.4×
- Environmental Science 0.2×
- Social Sciences 0.2×
- Arts and Humanities 0.2×
- Psychology 0.1×
- Biochemistry, Genetics and Molecular Biology 0.1×
- Engineering 0.1×
Who are the top researchers at National Centre for Pharmacoeconomics?
Ranked on the composite score, Michael Barry, Laura McCullagh and Róisín Adams lead among researchers whose main affiliation is National Centre for Pharmacoeconomics.
- 1 Michael Barry Ireland · #300,304 worldwide 151 citations · 52 works
- 2 Laura McCullagh Ireland · #1,560,658 worldwide 5 citations · 20 works
- 3 Róisín Adams Ireland · #1,584,697 worldwide 6 citations · 18 works
Which keywords describe research at National Centre for Pharmacoeconomics?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Lymphoma, Cancer Immunotherapy, Immunotherapy, CAR T Cells and Chimeric Antigen Receptor.
- Obesity
- Weight Loss
- SARS-CoV-2
- Health Outcomes
- Drug Development Costs
- Clinical Guidelines
- Pandemic
- Cost of Care
- Management
- CAR T Cells
- Cancer Immunotherapy
- Epidemiology
- Cost-effectiveness Analysis
- Quality of Life
- Health Utility Measures
- Lymphoma
- Immunotherapy
- Chimeric Antigen Receptor
- Clinical Trials
- Financial Toxicity
- ACE2 Receptor
- Inflammation
- Generic Drugs
- Medication Adherence
- Type 2 Diabetes
- Machine Learning
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 26 words, with their numbers
- Quality of Life6▲ 13×5 topics
- Cost-effectiveness Analysis5▲ 203×1 topic
- Health Utility Measures5▲ 203×1 topic
- Epidemiology3▲ 2.3×15 topics
- Lymphoma2▲ 39×2 topics
- Cancer Immunotherapy2▲ 37×2 topics
- Immunotherapy2▲ 8.1×2 topics
- CAR T Cells2▲ 73×1 topic
- Chimeric Antigen Receptor2▲ 73×1 topic
- Management2▲ 6.7×4 topics
- Clinical Trials2▲ 7.3×5 topics
- Cost of Care1▲ 160×1 topic
- Financial Toxicity1▲ 160×1 topic
- Pandemic1▲ 4.2×4 topics
- ACE2 Receptor1▲ 17×3 topics
- Clinical Guidelines1▲ 14×4 topics
- Inflammation1▲ 2.1×7 topics
- Drug Development Costs1▲ 156×1 topic
- Generic Drugs1▲ 156×1 topic
- Health Outcomes1▲ 15×4 topics
- Medication Adherence1▲ 73×2 topics
- SARS-CoV-21▲ 12×2 topics
- Type 2 Diabetes1▲ 18×2 topics
- Weight Loss1▲ 25×3 topics
- Machine Learning1◆ 1.02×2 topics
- Obesity1▲ 4.6×4 topics
Which research topics does National Centre for Pharmacoeconomics publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, CAR-T cell therapy research, Economic and Financial Impacts of Cancer and Pharmaceutical Economics and Policy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 5 works
- 2 CAR-T cell therapy research Oncology 2 works
- 3 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 4 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
- 5 Hemophilia Treatment and Research Hematology 1 works
- 6 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 7 Quality and Safety in Healthcare Medical Laboratory Technology 1 works
- 8 Asthma and respiratory diseases Physiology 1 works
- 9 Long-Term Effects of COVID-19 Neurology 1 works
- 10 COVID-19 Clinical Research Studies Infectious Diseases 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has National Centre for Pharmacoeconomics's research output changed?
Output in 2018–2022 was 7% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Dublin
- University College Dublin
- Trinity College Dublin
- Dublin City University
- Royal College of Surgeons in Ireland
- St. James's Hospital
- St. Vincent's University Hospital
- Technological University Dublin
- National University of Ireland
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.